The pharmaceutical sector is experiencing a significant shift in diabetes care with the emergence of GLP-1 patches. These groundbreaking methods offer a likely simple alternative to needle injections for individuals dealing with type 2 diabetes. By avoiding the necessity for frequent needles, GLP